Irritable Bowel Syndrome


Up to $270


Irritable Bowel Syndrome (IBS)

Official Title

Irritable Bowel Syndrome

Study Summary

A study to evaluate the effectiveness of oral doses of Blautix in adult subjects with irritable bowel syndrome (IBS).

Eligibility and Recruitment Information

Recruitment Status Recruiting
Eligible Genders Both
Eligible Ages 18+
Inclusion Having IBS-C or IBS-D
Exclusion Confirmed clinical diagnosis of bile acid malabsorption and / or on medication for bile acid malabsorption. Females who are pregnant or breast feeding
Start Date
Compensation Up to $270
Location Orlando, FL

Study Information

Condition Irritable Bowel Syndrome

Administrative Information

Study ID General Health

Apply for this study

Please include your first name.
Please include your last name.
Please include a valid email address.
Thank you for applying.
Sorry, something wen't wrong. Please contact us for support.